15-129
Showing 1 - 25 of >10,000
Asthma, COPD, Bronchiectasis Trial in Hamilton (Hyperpolarized 129Xe MRI)
Recruiting
- Asthma
- +7 more
- Hyperpolarized 129Xe MRI
-
Hamilton, Ontario, CanadaFirestone Institute for Respiratory Health, St. Joseph's Healthc
Sep 7, 2022
Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+
Recruiting
- Epstein-Barr Virus (EBV)-Associated Diseases
- +13 more
- Tabelecleucel
-
Los Angeles, California
- +39 more
Nov 9, 2022
Recent-Onset Type 1 Diabetes Extension Study Evaluating
Enrolling by invitation
- Type 1 Diabetes Mellitus
- Teplizumab
- Placebo
-
San Diego, California
- +41 more
Jan 31, 2023
COPD Trial (MagniXene Hyperpolarized Xenon MRI)
Not yet recruiting
- COPD
- MagniXene Hyperpolarized Xenon MRI
- (no location specified)
Jul 5, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial in Worldwide (CBP-201, Placebo)
Terminated
- Chronic Rhinosinusitis With Nasal Polyps
- CBP-201
- Placebo
-
Birmingham, Alabama
- +67 more
Jun 29, 2022
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,
Recruiting
- Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
- +4 more
- tabelecleucel
-
Duarte, California
- +70 more
Jun 23, 2022
Lung Transplant Rejection Trial in Philadelphia (Hyperpolarized 129-Xenon (MagniXene) MRI of the lung)
Recruiting
- Lung Transplant Rejection
- Hyperpolarized 129-Xenon (MagniXene) MRI of the lung
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 22, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
NSCLC?EGFR Sensitive Mutation Trial in Bengbu, Changsha, Shanghai (MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100
Not yet recruiting
- Non-Small Cell Lung CancerãEGFR Sensitive Mutation
- MCLA-129: 1500mg or 2000mg IV Q2W
- Befotertinib: 75 mg or 100 mg Po QD
-
Bengbu, Anhui, China
- +2 more
Aug 28, 2023
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell
Recruiting
- Pulmonary
- +2 more
- 29-XeMRI imaging
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2022
Advanced Solid Tumours Trial (EBC-129, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumours
- (no location specified)
Jan 18, 2023
Radiation Injury Trial in Durham (Hyperpolarized 129-Xenon gas, MRI)
Completed
- Radiation Injury
- Hyperpolarized 129-Xenon gas
- MRI
-
Durham, North CarolinaDuke University Medical Center
Mar 2, 2022
Healthy Volunteers Trial in Barcelona (ORG-129, Placebo)
Completed
- Healthy Volunteers
- ORG-129
- Placebo
-
Barcelona, Catalonia, SpainInstitut de Recerca de l'Hospital de la Santa Creu i de Sant Pau
Jan 13, 2023
Hyperpolarized Xenon-129 Lung Magnetic Resonance Imaging:
Recruiting
- Healthy
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Aug 16, 2021
Fibrostenotic Crohn's Disease Trial (AGMB-129, Placebo)
Not yet recruiting
- Fibrostenotic Crohn's Disease
- AGMB-129
- Placebo
- (no location specified)
May 3, 2023
Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism Trial in Durham
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperpolarized Xe129
- Oxygen Administration
-
Durham, North CarolinaDuke University Medical Center
Sep 8, 2023
Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung
Not yet recruiting
- Progressive Fibrosing Interstitial Lung Disease
- Hyperpolarized xenon-129 MRI
-
Aarhus, DenmarkAarhus University, Department of Clinical Medicine, MR Research
Jun 19, 2023
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib (ACP-196)
- +3 more
-
Chandler, Arizona
- +156 more
Jun 2, 2022
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients
Not yet recruiting
- COPD
- Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
- (no location specified)
Apr 3, 2023
Sleep Apnea From Data Acquired by a Wearable Smartwatch
Active, not recruiting
- Sleep Apnea
- Simultaneous assessment of sleep apnea by polysomnogram and wearable device
-
Jasper, Alabama
- +5 more
Aug 18, 2022
Hypercholesterolemia Trial (simvastatin (+) ezetimibe, Comparator: atorvastatin)
Completed
- Hypercholesterolemia
- simvastatin (+) ezetimibe
- Comparator: atorvastatin
- (no location specified)
Feb 7, 2022